Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

168
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
168
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

157
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise as a vital sign in cardiopulmonary disease: insights from wave intensity analysis.

American journal of physiology. Heart and circulatory physiology·2025
Same author

The effect of microvascular remodeling on fluid dynamics in the pressure-overloaded right ventricle.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia.

American journal of physiology. Lung cellular and molecular physiology·2025
Same author

Honokiol and Nicotinamide Adenine Dinucleotide Improve Exercise Endurance in Pulmonary Hypertensive Rats Through Increasing SIRT3 Function in Skeletal Muscle.

International journal of molecular sciences·2024
Same author

A bovine model of hypoxia-induced pulmonary hypertension reveals a gradient of immune and matrisome response with a complement signature found in circulation.

American journal of physiology. Cell physiology·2024
Same author

Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia.

Physiological genomics·2024

Related Experiment Video

Updated: Jun 23, 2025

Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels
07:17

Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels

Published on: June 30, 2023

1.7K

Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms.

Hui Zhang1, Min Li1, Cheng-Jun Hu1,2

  • 1Cardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.

Cells
|June 19, 2024
PubMed
Summary

Pulmonary hypertension (PH) involves significant vascular remodeling. Adventitial fibroblasts, not just intima and media cells, critically drive PH pathogenesis through sustained proliferation and inflammation.

Keywords:
adventitial fibroblastepigeneticsgene regulationhypoxiainflammationmetabolismmitochondrialpulmonary arterial hypertensionvascular remodeling

More Related Videos

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
07:11

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

136
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

294

Related Experiment Videos

Last Updated: Jun 23, 2025

Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels
07:17

Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels

Published on: June 30, 2023

1.7K
Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
07:11

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

136
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

294

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Pulmonary Medicine

Background:

  • Fibroblasts are key to tissue structure, homeostasis, and disease via extracellular matrix remodeling.
  • Pulmonary hypertension (PH) is characterized by pulmonary vasculature remodeling, affecting intima, media, and adventitia.
  • Adventitial fibroblasts are increasingly recognized for their critical role in PH pathogenesis.

Purpose of the Study:

  • To review the aberrant phenotypes of pulmonary artery adventitial fibroblasts in PH.
  • To discuss molecular signaling pathways driving these activated fibroblast phenotypes.
  • To highlight research areas for novel PH therapeutic targets.

Main Methods:

  • Review of recent scientific literature on pulmonary hypertension and fibroblast biology.
  • Analysis of cellular and molecular mechanisms underlying fibroblast activation in PH.
  • Identification of key signaling pathways implicated in fibroblast-driven PH.

Main Results:

  • Pulmonary artery adventitial fibroblasts display early, pronounced, and persistent proliferative, anti-apoptotic, and inflammatory responses in PH.
  • These fibroblasts contribute significantly to vascular remodeling and disease progression.
  • Specific molecular pathways are identified as crucial drivers of aberrant fibroblast behavior.

Conclusions:

  • Pulmonary artery adventitial fibroblasts are central players in PH pathogenesis.
  • Targeting activated fibroblast phenotypes and their signaling pathways offers potential for PH treatment.
  • Further research is needed to fully elucidate these mechanisms and develop effective therapies.